Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-368.26%Return on Equity
VS
Market
Sector
Industry
History
$ 1.6Close
$ 1.39 - $ 261.66 52-Week Range
Ticker Information
Ticker
APVOCompany Name
APTEVO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAPTEVO THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APVO - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 6.52M | $ -24.02M | -368.26% |
| 3/31/2025 | $ -1.47M | $ -23.7M | 0% |
| 12/31/2024 | $ 4.75M | $ -24.13M | -507.47% |
| 9/30/2024 | $ 4.42M | $ -23.72M | -536.67% |
| 6/30/2024 | $ 4.46M | $ -24.95M | -559.13% |
| 3/31/2024 | $ 6.1M | $ -27.02M | -442.72% |
| 12/31/2023 | $ 12.22M | $ -17.41M | -142.47% |
| 9/30/2023 | $ 14.72M | $ -16.15M | -109.74% |
| 6/30/2023 | $ 16.25M | $ -17.46M | -107.43% |
| 3/31/2023 | $ 23.26M | $ 18.5M | 79.54% |
Key Performance Insights, Last 5 Years
- APTEVO THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -856.99%.
- Over the past 5 years, APTEVO THERAPEUTICS INC's average ROE has been -375.47%.
- The median ROE for APTEVO THERAPEUTICS INC during this period was -237.4%
- APTEVO THERAPEUTICS INC reached its highest ROE over the past 5 years at 79.54%.
- The lowest ROE recorded by APTEVO THERAPEUTICS INC in the same timeframe -2340.21%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for APTEVO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -18.87M ] / Equity [ $ 2.2M ]
(=) ROE [ -856.99% ] APVO - Return on Equity, Last 5 years
-2340.21%
Minimum
Dec 31, 2021
79.54%
Maximum
Mar 31, 2023
-375.47%
Average
-237.4%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |